+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing with China: China - Licensing for Development and Commercialization Most Recent 100

  • ID: 5187907
  • Report
  • October 2020
  • Region: Global, China
  • 90 pages
  • Life Science Licensing
1 of 4
This trends report provides a comprehensive analysis on the most recent 100 licensing deals and negotiations reported for the healthcare companies of China for Development and Commercialization during January 1, 2019 to September 30, 2020, categorized and summarized by various important aspects such as key countries, healthcare sub-sectors, market capitalization groups, medicine groups, across key regions, licensing payment arrangements, and worldwide vs domestic licensing. Such detailed analysis helps to understand the licensing trends and directions during this time period in the healthcare segments of China for Licensing for Development and Commercialization. The report is extremely useful for the executives negotiating licensing deals for Development and Commercialization, as well as for the investors analyzing varied kinds of transaction options for licensing deals in China for Development and Commercialization. The report provides comprehensive information with twenty one months’ healthcare licensing transactions of China for Development and Commercialization analyzed at one place. The licensing trends and directions are summarized here after an in-depth analysis based on the comprehensive news gathering followed by insightful research.
Note: Product cover images may vary from those shown
2 of 4
Introduction

Research Design

Chapter 1: Analysis of most recent 100 healthcare inventions of China for Development and Commercialization licensed during last twenty one months
1.1 Companies with most licensing deals for China and other countries
1.2 Healthcare sub-sectors with most licensing deals
1.3 Market capitalization groups with most licensing deals
1.4 Medicine groups most active in licensing deals
1.5 Licensing payment arrangements most followed
1.6 Worldwide licensing vs domestic licensing

Chapter 2: Analysis of most recent 100 licensing deals of China for Development and Commercialization by key attributes during last twenty one months
2.1 For each of the key countries
2.2 For each of the healthcare sub-sectors
2.3 For each of the marketcap groups
2.4 For each of the medicine groups
2.5 Across each of the regions

Chapter 3: Summary and conclusions

Appendices
Appendix 1 Most recent 100 healthcare inventions licensed for China for Development and Commercialization during last twenty one months - By company name
Appendix 2 List of companies/institutes covered - By country and company name
Appendix 3 List of companies/institutes covered - By sub-industry and company name
Appendix 4 List of companies/institutes covered - By market capitalization group and company name
Appendix 5 List of non-listed companies covered - By country and company name
Appendix 6 List of not-for-profit groups covered - By country and institute name
Appendix 7 List of companies/institutes covered - By medicine group and company name
Appendix 8 List of companies/institutes covered - By terms of payment and company name
Appendix 9 Licensing deals discontinued for China for Development and Commercialization during last twenty one months
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

Loading
LOADING...

Adroll
adroll